GMAB - Genmab AS - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

GMAB is currently covered by 7 analysts with an average price target of $34.88. This is a potential upside of $6.41 (22.51%) from yesterday's end of day stock price of $28.47.

Genmab AS's activity chart (see below) currently has 48 price targets and 80 ratings on display. The stock rating distribution of GMAB is 6.52% HOLD, 65.22% BUY and 28.26% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.49% with an average time for these price targets to be met of 46.36 days.

Highest price target for GMAB is $50, Lowest price target is $32, average price target is $34.88.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 04-Apr-2024.

Currently out of the existing stock ratings of GMAB, 3 are a HOLD (6.52%), 30 are a BUY (65.22%), 13 are a SELL (28.26%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

50

$21.03 (72.59%)

50

20 days ago

9/31 (29.03%)

$20.35 (68.63%)

131

Buy

50

$21.03 (72.59%)

50

29 days ago

6/11 (54.55%)

$19.17 (62.18%)

87

Sell

32

$3.03 (10.46%)

32

29 days ago

16/17 (94.12%)

$1.17 (3.80%)

146

Buy

48

$19.03 (65.69%)

34.73

2 months 1 days ago

1/2 (50%)

$18.84 (64.61%)

26

Buy

46

$17.03 (58.78%)

44

6 months 11 days ago

0/2 (0%)

$13.72 (42.50%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMAB (Genmab AS) average time for price targets to be met?

On average it took 46.36 days on average for the stock forecasts to be realized with a an average price target met ratio 27.49

Which analyst has the current highest performing score on GMAB (Genmab AS) with a proven track record?

MATTHEW HARRISON

Which analyst has the most public recommendations on GMAB (Genmab AS)?

Matthew Harrison works at MORGAN STANLEY and has 13 price targets and 7 ratings on GMAB

Which analyst is the currently most bullish on GMAB (Genmab AS)?

Raghuram Selvaraju with highest potential upside - $21.03

Which analyst is the currently most reserved on GMAB (Genmab AS)?

Kennen Mackay with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?